Type 2 diabetes: target HbA1c of about 7%


Prescrire International 18(102): 177

2009


ISSN/ISBN: 1167-7422
PMID: 19746575
Document Number: 632085
A 17-year follow-up study of patients with type 2 diabetes enrolled in the Ukpds trial has shown that glycaemic control targeting HbA1c levels of about 7% is associated with lower mortality.

Document emailed within 1 workday
Secure & encrypted payments